16 related articles for article (PubMed ID: 3490117)
1. Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line.
Kano Y; Akutsu M; Kasahara T; Sakamoto S
Eur J Cancer; 1991; 27(9):1141-5. PubMed ID: 1835625
[TBL] [Abstract][Full Text] [Related]
2. Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts.
Bökkerink JP; De Abreu RA; Stet EH; Damen FJ
Klin Padiatr; 1992; 204(4):293-8. PubMed ID: 1518268
[TBL] [Abstract][Full Text] [Related]
3. Increased availability of phosphoribosyl pyrophosphate as the basis for enhanced 6-mercaptopurine incorporation by methotrexate, in cultured human lymphoblasts.
Bökkerink JP; de Abreu RA; van Laarhoven JP; Bakker MA; Hulscher TW; Schretlen ED; de Bruijn CH
Adv Exp Med Biol; 1986; 195 Pt B():135-9. PubMed ID: 2429504
[No Abstract] [Full Text] [Related]
4. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
5. Timing of maintenance chemotherapy for childhood acute lymphoblastic leukaemia.
Lévi F; Bailleul F; Misset JL; Reinberg A; Mathe G
Lancet; 1986 May; 1(8490):1160-1. PubMed ID: 2871414
[No Abstract] [Full Text] [Related]
6. Synergy of methotrexate and 6-mercaptopurine on cell growth and clonogenicity of cultured human T-lymphoblasts.
De Abreu RA; Bökkerink JP; Bakker MA; Hulscher TW; de Vaan GA; de Bruijn CH; Schretlen ED
Adv Exp Med Biol; 1986; 195 Pt B():129-34. PubMed ID: 3490117
[No Abstract] [Full Text] [Related]
7. Why more 6-mercaptopurine?
Kamen BA
Semin Hematol; 1991 Jul; 28(3 Suppl 4):12-4. PubMed ID: 1780746
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
